CAPSTONE INVESTMENT ADVISORS, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 24 filers reported holding CLOVIS ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2020$5,315,000
-0.9%
7,500,0000.0%0.02%
-33.3%
Q3 2020$5,362,000
+15.2%
7,500,0000.0%0.03%
-12.9%
Q2 2020$4,653,000
-2.0%
7,500,0000.0%0.03%
-59.2%
Q1 2020$4,746,000
-1.5%
7,500,0000.0%0.08%
+192.3%
Q4 2019$4,819,000
+50.2%
7,500,0000.0%0.03%
+18.2%
Q3 2019$3,209,000
-36.0%
7,500,000
-6.2%
0.02%
-38.9%
Q2 2019$5,017,000
-54.2%
8,000,000
-42.9%
0.04%
-64.4%
Q1 2019$10,961,000
+55.9%
14,000,000
+40.0%
0.10%
+16.1%
Q4 2018$7,029,000
+126.4%
10,000,000
+150.0%
0.09%
+148.6%
Q3 2018$3,105,000
-44.0%
4,000,000
-33.3%
0.04%
-58.8%
Q2 2018$5,544,0006,000,0000.08%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Castle Creek Arbitrage, LLC 3,000,000$1,874,0000.49%
Opti Capital Management, LP 4,500$2,815,0000.42%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 30,000,000$18,578,000,0000.36%
CAMDEN ASSET MANAGEMENT L P /CA 17,336,000$10,785,0000.34%
CSS LLC/IL 5,850,000$3,650,0000.21%
MIZUHO SECURITIES USA LLC 4,000,000$2,504,0000.12%
FARALLON CAPITAL MANAGEMENT LLC 18,750,000$11,684,0000.08%
ADVENT CAPITAL MANAGEMENT /DE/ 4,516,000$2,834,0000.06%
AQR Arbitrage LLC 7,350,000$4,609,0000.05%
ARROWGRASS CAPITAL PARTNERS (US) LP 8,000$1,562,0000.04%
View complete list of CLOVIS ONCOLOGY INC shareholders